Search This Blog

Friday, December 6, 2019

BeiGene agrees to allow Amgen to accumulate additional shares

Citing an increase in the number of outstanding shares due to option exercises and vesting of restricted share units, BeiGene (NASDAQ:BGNE) and cancer collaboration partner Amgen (NASDAQ:AMGN) have agreed to increase the number of shares allowable to the latter in order for it to maintain its 20.5% stake.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.